These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 578061)

  • 1. Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy.
    Eigenmann JE; Becker M; Kammermann B; Leemann W; Heimann R; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):818-22. PubMed ID: 578061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-suppressible insulin-like activity during acute metabolic and endocrine changes in dogs.
    Eigenmann JE; Francke-Mäder M; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):571-8. PubMed ID: 577341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation.
    Eigenmann JE; Becker M; Kammermann B; Zapf J; Leemann W; Froesch ER
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):498-503. PubMed ID: 579020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
    Megyesi K; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1975 Sep; 41(3):475-84. PubMed ID: 169287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs.
    Schlumpf U; Heimann R; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):28-42. PubMed ID: 946140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different extraction procedures on two different molecular weight species of serum NSILA and on the carrier protein of small molecular weight NSILA (NSILA-S).
    Kaufmann U; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):637-47. PubMed ID: 34963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats.
    Franklin RC; Rennie GC; Cameron DP
    J Endocrinol; 1979 Jun; 81(3):331-7. PubMed ID: 469463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in glucose metabolism and endocrine function in the remnant pancreas after major pancreatectomy, with special reference to the function of the anti-insulin system in Sandmeyer's diabetes (author's transl)].
    Tamaki H
    Nihon Naibunpi Gakkai Zasshi; 1980 Jul; 56(7):962-72. PubMed ID: 7007103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-hormone dependence of non-suppressible insulin-like activity (NSILA) and of NSILA-carrier protein in rats.
    Kaufmann U; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):716-27. PubMed ID: 580518
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay for non-suppressible insulin-like activity.
    Reber K; Liske R
    Horm Res; 1976; 7(4-5):201-13. PubMed ID: 1017791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine influences on serum acid-ethanol soluble non-suppressible in insulin-like activity (NSILA-S).
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):127-36. PubMed ID: 6772355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New studies on the nature of the non-suppressible insulin-like activity (NSILA) of human serum].
    Oelz O; Jakob A; Froesch ER
    Schweiz Med Wochenschr; 1970 Mar; 100(12):539-42. PubMed ID: 5417342
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of blood glucose in totally pancreatectomized dogs by use of pancreatic chambers.
    Araki Y; Inoue Y; Yoshioka K; Nakamura Y; Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Apr; 27(2):157-61. PubMed ID: 6997024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-suppressible insulin-like activity in Laron's syndrome.
    Kastrup KW; Zapf J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):414-20. PubMed ID: 425784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.